RUA Medical is delighted to announce that AorTech has completed its acquisition of the company.
David Richmond has become not only the new Group CEO but largest individual shareholder. AorTech International PLC, a company listed on the AIM market of the London Stock Exchange, will change its name to RUA Life Sciences PLC. It is also intended to re-brand all Group businesses under the RUA banner to help build upon RUA’s first class reputation in the global devices industry. RUA Medical will remain a full-service medical device subcontract manufacturer and is unique in its chosen area of expertise by offering a truly end to end service. RUA Medical will continue to serve its existing customers with the same people and facilities, and provide the quality of products and service previously enjoyed. More information on the acquisition can be found via the link https://www.aortech.net/